KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Neogenomics (NEO) over the last 13 years, with Q3 2025 value amounting to 0.14%.

  • Neogenomics' Return on Invested Capital fell 400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.1% for FY2024, which is 0.0% changed from last year.
  • Per Neogenomics' latest filing, its Return on Invested Capital stood at 0.14% for Q3 2025, which was down 400.0% from 0.13% recorded in Q2 2025.
  • Neogenomics' Return on Invested Capital's 5-year high stood at 0.01% during Q1 2021, with a 5-year trough of 0.15% in Q3 2022.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.1% (2023), whereas its average is 0.1%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first plummeted by -1200bps in 2022, then surged by 500bps in 2023.
  • Over the past 5 years, Neogenomics' Return on Invested Capital (Quarter) stood at 0.06% in 2021, then crashed by -142bps to 0.14% in 2022, then grew by 27bps to 0.1% in 2023, then grew by 4bps to 0.1% in 2024, then tumbled by -43bps to 0.14% in 2025.
  • Its Return on Invested Capital was 0.14% in Q3 2025, compared to 0.13% in Q2 2025 and 0.1% in Q1 2025.